Publication: A cost-effectiveness analysis of using umbilical cord blood pH for the diagnosis and management of neonatal asphyxia in term high-risk pregnancy
1
0
Issued Date
2024-10-01
Resource Type
ISSN
00207292
eISSN
18793479
Scopus ID
2-s2.0-85190961326
Pubmed ID
38619288
Journal Title
International Journal of Gynecology and Obstetrics
Volume
167
Issue
1
Start Page
281
End Page
286
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Gynecology and Obstetrics Vol.167 No.1 (2024) , 281-286
Suggested Citation
Winiyom P., Janyoungsak P., Narkwichean A., Khuancharee K., Laosooksathit W. A cost-effectiveness analysis of using umbilical cord blood pH for the diagnosis and management of neonatal asphyxia in term high-risk pregnancy. International Journal of Gynecology and Obstetrics Vol.167 No.1 (2024) , 281-286. 286. doi:10.1002/ijgo.15540 Retrieved from: https://hdl.handle.net/20.500.14740/20833
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Objective: The objective was to evaluate the cost-effectiveness of using umbilical cord blood pH (UC-pH) in combination with APGAR score for neonatal asphyxia, in terms of high-risk pregnancies, compared to using the APGAR score only. Neonatal outcomes and the proportions of patients admitted to the neonatal intensive care unit (NICU) were evaluated. Methods: A cost-effectiveness ambispective analysis study was carried out, comparing (i) UC-pH combined with APGAR score and (ii) APGAR score only in 399 term pregnancies with a high risk for neonatal asphyxia. Costs included implementation, medical, and admission costs. Incremental cost-effectiveness ratios (ICER) were calculated. The proportions of patients admitted to the NICU were evaluated. Results: UC-pH combined with APGAR score demonstrated a cost-effective outcome (3990.64 USD vs 5545.11 USD) and an ICER shown as saving 103.66 USD compared to the APGAR score alone. The need for NICU admission was less in the umbilical cord blood collection group (18 vs 33 cases). Conclusion: A combination of UC-pH with APGAR score assessment for neonatal asphyxia in a high-risk term pregnancy can effectively reduce costs and requirement for NICU admission.